Literature DB >> 10711698

Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.

M Yoshida1, M Takeuchi, J W Streilein.   

Abstract

PURPOSE: To determine by what mechanism(s) iris and ciliary body (I/CB) pigment epithelial (PE) cells inhibit T-cell activation in vitro.
METHODS: Pure cultured I/CB PE cells were obtained from eyes of normal and CD95 ligand (CD95L)deficient mice and tested for their capacity to suppress T-cell activation in three different T-cell receptor (Tcr) ligand systems: mixed lymphocyte reactions, stimulation of Tcr transgenic T cells (D011.10) by specific antigen (ovalbumin), and ligation of the Tcr-associated CD3 molecule by anti-CD3 antibodies. Proliferation and secretion of cytokines (interferon [IFN]-gamma, interleukin [IL]-2, IL-4, and IL-10) were assessed as measures of T-cell activation. Suppressive influences of I/CB PE cells were determined on the basis of RT-PCR- detected cytokine genes expressed by I/CB PE cells, immunosuppression mediated by supernatants of cultured I/CB PE cells, direct contact between I/CB PE cells and T lymphocytes, and promotion of apoptosis among responding T cells. Attempts to reverse I/CB PE-dependent suppression of T-cell activation included the use of neutralizing antibodies to IL-10, tumor necrosis factor (TNF)-alpha and transforming growth factor (TGF)-beta, and the addition of exogenous IL-2 and IL-12.
RESULTS: Cultured mouse I/CB PE cells (including CD95L-deficient cells), which were more than 95% keratin positive, suppressed T-cell proliferation and secretion of IFN-gamma, IL-2, IL-4, and IL-10 in a dose-dependent fashion in all three Tcr ligand systems. Supernatants of cultured I/CB PE cells displayed little suppression activity, whereas cultures in which I/CB PE cells contacted responding T cells directly were profoundly immunosuppressive. Cultured I/CB PE cells expressed mRNA for TGF-beta1, TGF-beta2, IL-6, IL-10, and TNF-alpha, but not IL-4, IFN-gamma, proopiomelanocortin (POMC), and CD95L (Fas L). Antibodies to TGF-beta, IL-10, and TNF-alpha failed to reverse suppression mediated by I/CB PE cells. Moreover, neither exogenous IL-2 or IL-12 relieved the suppression.
CONCLUSIONS: Cultured I/CB PE cells, through direct cell-to-cell contact, prevent T cells from proliferating and secreting cytokines when stimulated through the Tcr for antigen by a mechanism that does not involve CD95 or apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711698

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Surgical denervation of ocular sympathetic afferents decreases local transforming growth factor-beta and abolishes immune privilege.

Authors:  Jose L Vega; Hiroshi Keino; Sharmila Masli
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

Review 2.  Immune escape mechanisms of intraocular tumors.

Authors:  Jerry Y Niederkorn
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

Review 3.  Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates.

Authors:  Ravid Shechter; Anat London; Michal Schwartz
Journal:  Nat Rev Immunol       Date:  2013-03       Impact factor: 53.106

4.  Inhibitory effect of dexamethasone on TGF-beta1 expression of rabbit ciliary pigment epithelia cultured in vitro.

Authors:  Xinchun Xiong; Zulian Xi; Juan Miao; Qinglin Li; Haijiang Zhang; Yizhen Hu; Houren Wei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  Inducible immune regulation following autoimmune disease in the immune-privileged eye.

Authors:  Nobuyoshi Kitaichi; Kenichi Namba; Andrew W Taylor
Journal:  J Leukoc Biol       Date:  2005-01-12       Impact factor: 4.962

6.  Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?

Authors:  Jerry Y Niederkorn
Journal:  Front Immunol       Date:  2012-06-13       Impact factor: 7.561

Review 7.  Immunopathogenic Background of Pars Planitis.

Authors:  Joanna Przeździecka-Dołyk; Agnieszka Węgrzyn; Anna Turno-Kręcicka; Marta Misiuk-Hojło
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-10-05       Impact factor: 4.291

Review 8.  The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy.

Authors:  Jean-Pierre Routy; Bertrand Routy; Gina M Graziani; Vikram Mehraj
Journal:  Int J Tryptophan Res       Date:  2016-10-12

Review 9.  Immune Privilege and Eye-Derived T-Regulatory Cells.

Authors:  Hiroshi Keino; Shintaro Horie; Sunao Sugita
Journal:  J Immunol Res       Date:  2018-05-20       Impact factor: 4.818

10.  Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.

Authors:  Sunao Sugita; J Wayne Streilein
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.